STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #6 by analyst upside · 2026-09-22
SNYRQ
Synergy CHC Corp.
Healthcare · Market Cap $1M · P/E 0x
ANALYST PRICE TARGET
+9046.3%
implied upside to consensus target
Current Price $0.04
Consensus Target $3.75
Bull Target $3.75
Bear Target $3.75
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $0.03
52-Week High $2.96
YTD Return -97.8%
FUNDAMENTALS
Market Cap $1M
P/E Ratio (TTM) N/A
Forward P/E 0.3x
EPS (TTM) $-1.60
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $28M
Profit Margin -57.0%
52-WEEK RANGE
52-Week Low $0.03
52-Week High $2.96
Current Price $0.04
Bear Target $3.75
Bull Target $3.75
● Now $0.04 ● Target $3.75
TRADING DATA
Avg Volume 30.7M
YTD Return -97.8%
Analyst Count 1
Consensus Buy
Upside to Target +9046.3%
Last Updated 2026-09-22

ANALYST SUMMARY

Synergy CHC Corp. (SNYRQ) is currently trading at $0.04 with a Wall Street consensus price target of $3.75, implying potential upside of 9046.3% over the next 12 months. 1 analysts currently cover SNYRQ, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.75, while the most cautious has a target of $3.75.

SNYRQ operates in the Healthcare sector with a market capitalisation of $1M. The stock is down 97.8% year-to-date and is currently trading near the lower end of its 52-week range of $0.03 – $2.96.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →